(191at) Blocking Lactic Acid Pathway for Enhanced HA Production in C. Glutamicum
AIChE Annual Meeting
2017
2017 Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Poster Session: Bioengineering
Monday, October 30, 2017 - 3:15pm to 4:45pm
Corynebacterium glutamicum (C. glutamicum) is a non-pathogenic, non-sporulating bacterium that generally recognized as safe (GRAS). It is an ideal alternative recombinant host for HA production. In our previous study, co-expressing HA synthase (HasA) from S. equisimilis and native UDP-glucose dehydrogenase gene (HasB) in engineered C. glutamicum successfully achieved 5-6 g/L HA titer in flask culture and 8-9 g/L HA titer in batch culture of 5L fermentor. In this work, a novel idea is further proposed to engineer the recombinant C. glutamicum for enhanced HA synthesis.
HA biosynthesis is an ATP consuming pathway. Every 2 mol glucose needs 5 mol ATPÂ equivalent to form a disaccharide unit. Lactate dehydrogenase (LDH) participates transforming 1 mol pyruvic acid to lactic acid, in which 2 mol ATPÂ equivalent was consumed. Blocking lactic acid pathway would enable more pyruvic acid flowing into TCA cycle and creating ATP. Therefore, a LDH-inactive C. glutamicum mutant (âldh) was constructed by single cross over homologous recombination. An engineered HA producer, C. glutamicum âldh-AB with HA synthesis operon (hasA-hasB) was further obtained through introducing C. glutamicum- E. coli shuttle plasmid pXMJ19-ssehasA-hasB (AB). In 5 L fermentor, the biomass and HA titer reached 14.7 g/L and 10.6 g/L, respectively, with 40g/L glucose as carbon source. To enhance the HA accumulation, glucose feeding strategy was further applied to keep residual glucose concentration higher than 8 g/L after 20 h. In the fed-batch culture, the maximal titer of HA achieved 21.6 g/L, which is the highest result reported so far. The Mw of the HA product consisted two part, 1.28 MDa (mass percentage 14.2%) and 290 KDa (mass percentage 85.8%), respectively.